CTI BioPharma Statistics
Total Valuation
Compass has a market cap or net worth of $4.33 billion. The enterprise value is $4.70 billion.
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Compass has 525.87 million shares outstanding. The number of shares has increased by 9.48% in one year.
| Current Share Class | 513.18M |
| Shares Outstanding | 525.87M |
| Shares Change (YoY) | +9.48% |
| Shares Change (QoQ) | +7.49% |
| Owned by Insiders (%) | 3.93% |
| Owned by Institutions (%) | 67.57% |
| Float | 457.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.88 |
| PS Ratio | 0.70 |
| Forward PS | 0.59 |
| PB Ratio | 5.99 |
| P/TBV Ratio | 176.14 |
| P/FCF Ratio | 29.48 |
| P/OCF Ratio | 26.45 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 31.99 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.75.
| Current Ratio | 0.74 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 4.54 |
| Debt / FCF | 3.72 |
| Interest Coverage | -11.81 |
Financial Efficiency
Return on equity (ROE) is -9.56% and return on invested capital (ROIC) is -5.57%.
| Return on Equity (ROE) | -9.56% |
| Return on Assets (ROA) | -4.36% |
| Return on Invested Capital (ROIC) | -5.57% |
| Return on Capital Employed (ROCE) | -8.73% |
| Revenue Per Employee | $2.45M |
| Profits Per Employee | -$20,850 |
| Employee Count | 2,566 |
| Asset Turnover | 4.47 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.43% in the last 52 weeks. The beta is 2.61, so Compass's price volatility has been higher than the market average.
| Beta (5Y) | 2.61 |
| 52-Week Price Change | +93.43% |
| 50-Day Moving Average | 6.61 |
| 200-Day Moving Average | 7.08 |
| Relative Strength Index (RSI) | 73.80 |
| Average Volume (20 Days) | 7,853,898 |
Short Selling Information
The latest short interest is 33.60 million, so 6.39% of the outstanding shares have been sold short.
| Short Interest | 33.60M |
| Short Previous Month | 27.79M |
| Short % of Shares Out | 6.39% |
| Short % of Float | 7.35% |
| Short Ratio (days to cover) | 4.28 |
Income Statement
In the last 12 months, Compass had revenue of $6.29 billion and -$53.50 million in losses. Loss per share was -$0.10.
| Revenue | 6.29B |
| Gross Profit | 756.80M |
| Operating Income | -98.00M |
| Pretax Income | -236.10M |
| Net Income | -53.50M |
| EBITDA | -9.40M |
| EBIT | -98.00M |
| Loss Per Share | -$0.10 |
Full Income StatementBalance Sheet
The company has $177.30 million in cash and $546.70 million in debt, giving a net cash position of -$369.40 million or -$0.70 per share.
| Cash & Cash Equivalents | 177.30M |
| Total Debt | 546.70M |
| Net Cash | -369.40M |
| Net Cash Per Share | -$0.70 |
| Equity (Book Value) | 725.40M |
| Book Value Per Share | 1.38 |
| Working Capital | -125.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $163.80 million and capital expenditures -$16.80 million, giving a free cash flow of $147.00 million.
| Operating Cash Flow | 163.80M |
| Capital Expenditures | -16.80M |
| Free Cash Flow | 147.00M |
| FCF Per Share | $0.28 |
Full Cash Flow StatementMargins
Gross margin is 12.03%, with operating and profit margins of -1.56% and -0.85%.
| Gross Margin | 12.03% |
| Operating Margin | -1.56% |
| Pretax Margin | -0.91% |
| Profit Margin | -0.85% |
| EBITDA Margin | -0.15% |
| EBIT Margin | -1.56% |
| FCF Margin | 2.34% |
Dividends & Yields
Compass does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.48% |
| Shareholder Yield | -9.48% |
| Earnings Yield | -1.23% |
| FCF Yield | 3.39% |
Dividend DetailsAnalyst Forecast
The average price target for Compass is $9.57, which is 16.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.57 |
| Price Target Difference | 16.14% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 13.31% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Compass has an Altman Z-Score of 3.57 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.57 |
| Piotroski F-Score | 4 |
